🔎 Trials Near Me

Početna › HPV › Texas

Kliničke studije za HPV u državi Texas

6 studija za HPV traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

  • University of Texas Medical Branch, Galveston
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošliNavodi plaćanje za sudionike
Od 27 do 45 godina · Žene · Ažurirano 15. ruj 2026. · NCT05672927

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
  • UT Health Mays Cancer Center, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

  • UT MD Anderson Cancer Center, Houston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 25 godina i više · Žene · Ažurirano 31. srp 2026. · NCT07281430

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

  • The University of Texas Health Science Center at Houston, Houston
U tijeku regrutacija
Od 11 do 17 godina · Oba spola · Ažurirano 4. svi 2026. · NCT06598475

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

  • The Harris Health System (L.B.J Hospital), Houston
  • University of Texas, M.D. Anderson, Houston
U tijeku regrutacijaFaza 2
Od 25 do 100 godina · Žene · Ažurirano 2. lis 2025. · NCT04098744

HPV Vaccine, Imiquimod, and Metformin Combination Trial

  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Žene · Ažurirano 13. stu 2024. · NCT06686043

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.